查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1916570

全球生技原料市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Biotech Ingredients Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

生技原料市場成長因素

預計2025年全球生技原料市場規模將達23.2億美元，2026年將成長至25億美元，到2034年將達45.4億美元。市場成長的主要驅動力是製藥、化妝品、食品飲料和農業等行業對生物技術生產方法的日益普及。北美地區憑藉先進的生物製造基礎設施和高額研發投入，預計2025年將佔45%的市場佔有率，成為市場領導者。

生技原料的生產流程包括發酵、酵素合成、細胞培養、基因工程及合成生物學等。這些成分包括酵素、胺基酸、勝肽、維生素、益生菌和活性藥物成分 (API)。與合成原料相比，生物技術原料具有更高的純度、可持續性、可擴展性和一致性，這推動了其在受監管行業的應用。

市場成長驅動因素

關鍵驅動因素之一是消費品和工業領域對永續、清潔標籤成分的需求不斷增長。在食品和飲料行業，生物技術衍生的酵素和益生菌有助於改善消化、延長保質期並滿足清潔標籤要求。在化妝品產業，微生物衍生的透明質酸、勝肽和神經醯胺因其安全環保的來源而日益受到青睞。

在製藥業，生技原料對於生物製劑、疫苗、單株抗體和重組蛋白的生產至關重要。癌症、糖尿病和自體免疫疾病等慢性病發病率的上升導致人們對生物療法的依賴性增強，直接推高了對生物技術衍生活性成分 (API) 和輔料的需求。

市場限制因子

儘管成長前景強勁，但高昂的研發和生產成本仍是主要限制因素。生技原料的開發需要精密的實驗室設施、經驗豐富的科學家、漫長的研發週期以及嚴格的監管合規，尤其是對於藥品級生產。發酵和細胞培養系統需要精確的環境控制，增加了營運成本。

監管審批耗時更長，尤其是對於生物製劑而言，安全性、可追溯性和驗證至關重要。中小企業往往由於資金限製而難以擴大生產規模，這構成了市場准入和競爭力的障礙。

先進療法和生物相似藥驅動的市場機會

重磅生物製劑的專利到期正在加速生物相似藥的研發，從而對發酵衍生蛋白、培養基和純化試劑產生了強勁的需求。這一趨勢在腫瘤和自體免疫疾病治療領域尤為明顯。

細胞療法、基因療法、CAR-T療法和抗體藥物偶聯物等先進療法也在全球不斷擴展。這些療法需要病毒載體、重組細胞因子和工程蛋白等特殊的生物技術成分，從而在受監管的醫療保健市場中創造了新的長期需求。

監管與地緣政治因素帶來的市場挑戰

監管的複雜性仍然是一項重大挑戰。美國、歐洲和亞洲的審批框架各不相同，需要不同的文件、測試方案和環境評估。合成生物學和基因改造微生物菌株通常會受到額外的審查，從而延緩商業化進程。

地緣政治緊張局勢和貿易保護主義也在影響原料供應鏈。關稅、出口限制以及對中國和印度原材料供應的依賴，迫使製造商實現生產基地多元化，增加了資本支出和合規負擔。

細分市場分析：依原料及應用劃分

依原料劃分

市場依原料分為動物源性、植物源性及微生物源性原料。

2024年，動物源性原料佔主導地位，這主要得益於膠原蛋白、明膠和激素類化合物的高生物利用度，這些物質廣泛應用於藥品和營養補充劑中。

植物源原料市場正在成長，這得益於酵素輔助萃取技術的發展，以及素食需求和永續發展趨勢的推動。

預計到2026年，微生物源原料市場將佔全球市場佔有率的約46%，這主要得益於精準發酵、基於CRISPR的菌株優化以及高產微生物合成技術的進步。

依應用領域劃分

市場依應用領域可分為醫藥、食品飲料、個人護理及化妝品等領域。

預計到2026年，醫藥產業將佔市場佔有率的約45.60%，這主要得益於生物製劑、疫苗和重組活性藥物成分（API）需求的成長。

由於對益生菌、酵素和功能性蛋白的需求增加，食品飲料產業也在擴張。

由於生物技術勝肽、透明質酸和植物膠原蛋白等成分被應用於皮膚修復和抗衰老產品中，個人護理和化妝品行業正在蓬勃發展。

2024年，食品和飲料產業約佔市場佔有率的15.8%。

區域展望

北美

北美仍是最大的區域市場，預計2025年將達到10.6億美元，2026年將達到11.4億美元。光是美國預計到2026年市場規模就將達到9億美元，主要得益於對生物製造和清潔標籤化妝品的需求。

亞太地區

由於政府的大力支持和生物製造的擴張，亞太地區正在經歷快速成長。

預計2026年，中國市場規模將達到2.1億美元，印度將達到1.1億美元，日本將達到5,000萬美元，主要得益於製藥生產和發酵技術的投資。

歐洲

歐洲受益於永續發展法規和強大的生物技術研究。預計到2026年，德國市場規模將達2.6億美元，英國將達到1.1億美元。

拉丁美洲與中東/非洲

成長主要由製藥業的擴張和生物基化妝品成分的日益普及推動，尤其是在巴西和海灣國家。

競爭格局與產業趨勢

主要參與者包括奇華頓（Givaudan）、Codex InBiotech Ingredients、Covallo、帝斯曼-芬美意（dsm-firmenich）、Abel、贏創工業集團（Evonik Industries）、默克集團（Merck KGaA）、Conagen、Fermenta Biotech和Titan Biotech。這些公司專注於擴大發酵產能、推出永續成分並建立策略合作夥伴關係。

預計2024年至2025年間的主要發展包括私募股權投資、推出新型發酵衍生香料、基於人工智慧的成分配方工具、推出純素膠原蛋白以及在美國和亞洲擴建大型生物製造設施。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰

第四章：關鍵考慮因素

  • 全球主要市場趨勢
  • 主要趨勢：併購、業務合作等
  • 最新技術進展
  • 永續發展洞察
  • 波特五力分析
  • 關稅影響分析

第五章：全球生技原料市場分析：洞察與預測（2021-2034）

  • 主要分析結果/摘要
  • 依原料劃分
    • 微生物
    • 植物
    • 動物
  • 按應用領域劃分
    • 製藥
    • 食品飲料
    • 個人護理及化妝品
    • 其他
  • 按地區劃分
    • 北美
    • 歐洲
    • 亞太
    • 拉丁美洲
    • 中東和非洲

第六章：北美生技原料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國各州
    • 加拿大

第七章 歐洲生技原料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 其他歐洲國家

第八章 亞太地區生技原料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家

第九章 拉丁美洲生技原料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲生技原料市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲國家

第十一章：競爭格局

  • 市佔率/排名分析：依主要公司劃分（2025）
  • 公司簡介
    • 奇華頓

第十二章：公司資訊

  • Codex-ing Biotech Ingredients
    • Covalo
    • dsm-firmenich
    • Abel
    • Aesthetics Rx
    • Nikko Chemicals Co., Ltd.
    • Evonik Personal Care
    • Fermenta Biotech Limited
    • Titan Biotech
    • Conagen, Inc.
    • Advanced Biotech
    • Merck KGaA

第十三章 策略建議

Product Code: FBI113927

Growth Factors of biotech ingredients Market

The global biotech ingredients market size was valued at USD 2.32 billion in 2025 and is projected to grow to USD 2.50 billion in 2026, further reaching USD 4.54 billion by 2034. The market is expanding due to increasing adoption of biotechnology-based production methods across pharmaceuticals, cosmetics, food and beverages, and agriculture. In 2025, North America dominated the market with a 45% share, supported by advanced biomanufacturing infrastructure and high R&D investments.

Biotech ingredients are produced using processes such as fermentation, enzymatic synthesis, cell culture, genetic engineering, and synthetic biology. These ingredients include enzymes, amino acids, peptides, vitamins, probiotics, and active pharmaceutical ingredients (APIs). Compared to chemically synthesized ingredients, biotech ingredients offer higher purity, sustainability, scalability, and consistency, which strengthens their adoption in regulated industries.

Market Drivers Supporting Growth

One of the major drivers is the growing demand for sustainable and clean-label ingredients across consumer and industrial sectors. In food and beverages, biotechnology-derived enzymes and probiotics help improve digestion, enhance shelf life, and meet clean-label requirements. In cosmetics, microbial-derived hyaluronic acid, peptides, and ceramides are increasingly preferred due to safety and eco-friendly sourcing.

In pharmaceuticals, biotech ingredients are critical for producing biologics, vaccines, monoclonal antibodies, and recombinant proteins. Rising incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders is increasing reliance on biologic therapies, directly raising demand for biotech-derived APIs and excipients.

Market Restraints Limiting Expansion

Despite strong growth prospects, high R&D and production costs remain major restraints. Developing biotech ingredients requires sophisticated laboratory facilities, skilled scientists, long development cycles, and regulatory compliance, particularly in pharmaceutical-grade production. Fermentation and cell-culture systems require precise environmental control, increasing operational costs.

Regulatory approvals further extend timelines, especially in biologics manufacturing where safety, traceability, and validation are critical. Smaller companies often face difficulty scaling production due to limited capital availability, which restricts market entry and competitiveness.

Market Opportunities from Advanced Therapies and Biosimilars

Patent expirations of blockbuster biologics have accelerated the development of biosimilars, creating strong demand for fermentation-based proteins, growth media, and purification reagents. This trend is particularly strong in oncology and autoimmune disease treatment.

Advanced therapies such as cell therapies, gene therapies, CAR-T therapies, and antibody-drug conjugates are also expanding globally. These therapies require specialized biotech ingredients, including viral vectors, recombinant cytokines, and engineered proteins, creating new long-term demand streams across regulated healthcare markets.

Market Challenges from Regulatory and Geopolitical Factors

Regulatory complexity remains a significant challenge. Approval frameworks differ across the U.S., Europe, and Asia, requiring separate documentation, testing protocols, and environmental assessments. Synthetic biology and genetically modified microbial strains often face additional scrutiny, slowing commercialization.

Geopolitical tensions and trade protectionism are also affecting ingredient supply chains. Tariffs, export controls, and dependency on Chinese and Indian raw material sourcing are forcing manufacturers to diversify production locations, increasing capital expenditure and compliance burden.

Segmentation Analysis by Source and Application

By Source

The market is segmented into animal-based, plant-based, and microbial ingredients.

Animal-based ingredients dominated in 2024, driven by high bioavailability of collagen, gelatin, and hormone-based compounds used in pharmaceuticals and nutraceuticals.

Plant-based ingredients are growing due to vegan demand and sustainability trends, supported by enzyme-assisted extraction technologies.

The microbial segment is projected to contribute about 46% globally in 2026, driven by precision fermentation, CRISPR strain optimization, and high-yield microbial synthesis.

By Application

The market is segmented into pharmaceuticals, food and beverages, personal care and cosmetics, and others.

The pharmaceuticals segment held about 45.60% share in 2026, driven by biologics, vaccines, and recombinant APIs.

Food and beverages are expanding due to rising demand for probiotics, enzymes, and functional proteins.

Personal care and cosmetics are growing due to biotech peptides, hyaluronic acid, and vegan collagen used in skin repair and anti-aging products.

The food and beverages segment accounted for approximately 15.8% share in 2024.

Regional Outlook

North America

North America recorded USD 1.06 billion in 2025 and USD 1.14 billion in 2026, remaining the largest regional market. The U.S. alone is projected to reach USD 0.90 billion by 2026, supported by biologics manufacturing and clean-label cosmetic demand.

Asia Pacific

Asia Pacific is experiencing rapid growth due to strong government funding and expanding biomanufacturing.

China is projected to reach USD 0.21 billion by 2026, India USD 0.11 billion, and Japan USD 0.05 billion, driven by pharmaceutical production and fermentation investments.

Europe

Europe benefits from sustainability regulations and strong biotech research. Germany is projected to reach USD 0.26 billion by 2026, while the UK is expected to reach USD 0.11 billion.

Latin America and Middle East & Africa

Growth is supported by expanding pharmaceutical manufacturing and rising adoption of bio-based cosmetic ingredients, especially in Brazil and Gulf countries.

Competitive Landscape and Industry Developments

Major companies include Givaudan, Codex-ing Biotech Ingredients, Covalo, dsm-firmenich, Abel, Evonik Industries, Merck KGaA, Conagen, Fermenta Biotech, and Titan Biotech. These companies focus on expanding fermentation capacity, launching sustainable ingredients, and forming strategic partnerships.

Key developments include private equity investments, new fermentation-based flavor launches, AI-driven ingredient formulation tools, vegan collagen introductions, and large-scale biomanufacturing expansions in the U.S. and Asia during 2024-2025.

Conclusion

The biotech ingredients market is showing strong structural growth, with market value increasing from USD 2.32 billion in 2025 to USD 2.50 billion in 2026 and projected to reach USD 4.54 billion by 2034, supported by rising adoption across pharmaceuticals, food and beverages, and personal care applications. North America remains the leading region, while Asia Pacific is emerging as a high-growth manufacturing and R&D hub. Expansion of biologics, biosimilars, and advanced therapies is accelerating demand for fermentation-based proteins, enzymes, and recombinant APIs, while clean-label and sustainability trends are boosting plant-based and microbial ingredient development. Although high production costs and regulatory complexity continue to challenge market participants, ongoing investments in precision fermentation, synthetic biology, and AI-driven bioprocess optimization are improving scalability and efficiency, strengthening long-term industry competitiveness and widening commercial adoption across both healthcare and consumer sectors.

Segmentation By Source

  • Microbial
  • Plant-based
  • Animal-based

By Application

  • Pharmaceuticals
  • Food and Beverages
  • Personal Care & Cosmetics
  • Others

By Region

  • North America (By Source, By Application, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Source, By Application, and By Country)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Italy (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Source, By Application, and By Country)
    • China (By Application)
    • India (By Application)
    • Japan (By Application)
    • South Korea (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Source, By Application, and By Country)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Source, By Application, and By Country)
    • Saudi Arabia (By Application)
    • South Africa (By Application)
    • Rest of Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Trends
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Market Opportunities
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Key Market Trends in the Global Market
  • 4.2. Key Developments: Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Latest Technological Advancement
  • 4.4. Insights on Sustainability
  • 4.5. Porter's Five Forces Analysis
  • 4.6. Tariff Impact Analysis

5. Global Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. By Source
    • 5.2.1. Microbial
    • 5.2.2. Plant-based
    • 5.2.3. Animal-based
  • 5.3. By Application
    • 5.3.1. Pharmaceuticals
    • 5.3.2. Food and Beverages
    • 5.3.3. Personal Care & Cosmetics
    • 5.3.4. Others
  • 5.4. By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. By Source
    • 6.2.1. Microbial
    • 6.2.2. Plant-based
    • 6.2.3. Animal-based
  • 6.3. By Application
    • 6.3.1. Pharmaceuticals
    • 6.3.2. Food and Beverages
    • 6.3.3. Personal Care & Cosmetics
    • 6.3.4. Others
  • 6.4. By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
        • 6.4.1.1.1. Pharmaceuticals
        • 6.4.1.1.2. Food and Beverages
        • 6.4.1.1.3. Personal Care & Cosmetics
        • 6.4.1.1.4. Others
    • 6.4.2. Canada
      • 6.4.2.1. By Application
        • 6.4.2.1.1. Pharmaceuticals
        • 6.4.2.1.2. Food and Beverages
        • 6.4.2.1.3. Personal Care & Cosmetics
        • 6.4.2.1.4. Others

7. Europe Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. By Source
    • 7.2.1. Microbial
    • 7.2.2. Plant-based
    • 7.2.3. Animal-based
  • 7.3. By Application
    • 7.3.1. Pharmaceuticals
    • 7.3.2. Food and Beverages
    • 7.3.3. Personal Care & Cosmetics
    • 7.3.4. Others
  • 7.4. By Country
    • 7.4.1. Germany
      • 7.4.1.1. By Application
        • 7.4.1.1.1. Pharmaceuticals
        • 7.4.1.1.2. Food and Beverages
        • 7.4.1.1.3. Personal Care & Cosmetics
        • 7.4.1.1.4. Others
    • 7.4.2. UK
      • 7.4.2.1. By Application
        • 7.4.2.1.1. Pharmaceuticals
        • 7.4.2.1.2. Food and Beverages
        • 7.4.2.1.3. Personal Care & Cosmetics
        • 7.4.2.1.4. Others
    • 7.4.3. France
      • 7.4.3.1. By Application
        • 7.4.3.1.1. Pharmaceuticals
        • 7.4.3.1.2. Food and Beverages
        • 7.4.3.1.3. Personal Care & Cosmetics
        • 7.4.3.1.4. Others
    • 7.4.4. Italy
      • 7.4.4.1. By Application
        • 7.4.4.1.1. Pharmaceuticals
        • 7.4.4.1.2. Food and Beverages
        • 7.4.4.1.3. Personal Care & Cosmetics
        • 7.4.4.1.4. Others
    • 7.4.5. Rest of Europe
      • 7.4.5.1. By Application
        • 7.4.5.1.1. Pharmaceuticals
        • 7.4.5.1.2. Food and Beverages
        • 7.4.5.1.3. Personal Care & Cosmetics
        • 7.4.5.1.4. Others

8. Asia-Pacific Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. By Source
    • 8.2.1. Microbial
    • 8.2.2. Plant-based
    • 8.2.3. Animal-based
  • 8.3. By Application
    • 8.3.1. Pharmaceuticals
    • 8.3.2. Food and Beverages
    • 8.3.3. Personal Care & Cosmetics
    • 8.3.4. Others
  • 8.4. By Country
    • 8.4.1. China
      • 8.4.1.1. By Application
        • 8.4.1.1.1. Pharmaceuticals
        • 8.4.1.1.2. Food and Beverages
        • 8.4.1.1.3. Personal Care & Cosmetics
        • 8.4.1.1.4. Others
    • 8.4.2. India
      • 8.4.2.1. By Application
        • 8.4.2.1.1. Pharmaceuticals
        • 8.4.2.1.2. Food and Beverages
        • 8.4.2.1.3. Personal Care & Cosmetics
        • 8.4.2.1.4. Others
    • 8.4.3. Japan
      • 8.4.3.1. By Application
        • 8.4.3.1.1. Pharmaceuticals
        • 8.4.3.1.2. Food and Beverages
        • 8.4.3.1.3. Personal Care & Cosmetics
        • 8.4.3.1.4. Others
    • 8.4.4. South Korea
      • 8.4.4.1. By Application
        • 8.4.4.1.1. Pharmaceuticals
        • 8.4.4.1.2. Food and Beverages
        • 8.4.4.1.3. Personal Care & Cosmetics
        • 8.4.4.1.4. Others
    • 8.4.5. Rest of Asia-Pacific
      • 8.4.5.1. By Application
        • 8.4.5.1.1. Pharmaceuticals
        • 8.4.5.1.2. Food and Beverages
        • 8.4.5.1.3. Personal Care & Cosmetics
        • 8.4.5.1.4. Others

9. Latin America Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. By Source
    • 9.2.1. Microbial
    • 9.2.2. Plant-based
    • 9.2.3. Animal-based
  • 9.3. By Application
    • 9.3.1. Pharmaceuticals
    • 9.3.2. Food and Beverages
    • 9.3.3. Personal Care & Cosmetics
    • 9.3.4. Others
  • 9.4. By Country
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
        • 9.4.1.1.1. Pharmaceuticals
        • 9.4.1.1.2. Food and Beverages
        • 9.4.1.1.3. Personal Care & Cosmetics
        • 9.4.1.1.4. Others
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
        • 9.4.2.1.1. Pharmaceuticals
        • 9.4.2.1.2. Food and Beverages
        • 9.4.2.1.3. Personal Care & Cosmetics
        • 9.4.2.1.4. Others
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application
        • 9.4.3.1.1. Pharmaceuticals
        • 9.4.3.1.2. Food and Beverages
        • 9.4.3.1.3. Personal Care & Cosmetics
        • 9.4.3.1.4. Others

10. Middle East & Africa Biotech Ingredients Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. By Source
    • 10.2.1. Microbial
    • 10.2.2. Plant-based
    • 10.2.3. Animal-based
  • 10.3. By Application
    • 10.3.1. Pharmaceuticals
    • 10.3.2. Food and Beverages
    • 10.3.3. Personal Care & Cosmetics
    • 10.3.4. Others
  • 10.4. By Country
    • 10.4.1. Saudi Arabia
      • 10.4.1.1. By Application
        • 10.4.1.1.1. Pharmaceuticals
        • 10.4.1.1.2. Food and Beverages
        • 10.4.1.1.3. Personal Care & Cosmetics
        • 10.4.1.1.4. Others
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
        • 10.4.2.1.1. Pharmaceuticals
        • 10.4.2.1.2. Food and Beverages
        • 10.4.2.1.3. Personal Care & Cosmetics
        • 10.4.2.1.4. Others
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application
        • 10.4.3.1.1. Pharmaceuticals
        • 10.4.3.1.2. Food and Beverages
        • 10.4.3.1.3. Personal Care & Cosmetics
        • 10.4.3.1.4. Others

11. Competitive Landscape

  • 11.1. Company Market Share/Ranking Analysis, By Key Players, 2025
  • 11.2. Company Profiles
    • 11.2.1. Givaudan
      • 11.2.1.1. Overview
      • 11.2.1.2. Description
      • 11.2.1.3. Product Portfolio
      • 11.2.1.4. Financials (Data as available in the public domain and/or on paid databases)
      • 11.2.1.5. Recent Developments

12. Similar information has been provided for all the below companies

  • 12.1. Codex-ing Biotech Ingredients
    • 12.1.1. Covalo
    • 12.1.2. dsm-firmenich.
    • 12.1.3. Abel
    • 12.1.4. Aesthetics Rx
    • 12.1.5. Nikko Chemicals Co., Ltd.
    • 12.1.6. Evonik Personal Care
    • 12.1.7. Fermenta Biotech Limited
    • 12.1.8. Titan Biotech.
    • 12.1.9. Conagen, Inc.
    • 12.1.10. Advanced Biotech
    • 12.1.11. Merck KGaA

13. Strategic Recommendations

List of Tables

  • Table 1: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 2: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 3: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Region, 2021-2034
  • Table 4: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 5: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 6: North America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 7: U.S. Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 8: Canada Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 9: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 10: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 12: Germany Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 13: France Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 14: UK Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 15: Italy Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 16: Rest of Europe Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 17: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 18: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 20: China Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 21: India Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 22: Japan Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 23: South Korea Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 24: Rest of Asia Pacific Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 25: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 26: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 27: Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 28: Brazil Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 29: Mexico Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 30: Rest of Latin America Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 31: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Source, 2021-2034
  • Table 32: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 33: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 34: Saudi Arabia Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 35: South Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 36: Rest of Middle East & Africa Biotech Ingredients Market Revenue (USD Billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 1: Global Biotech Ingredients Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 2: Global Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 3: Global Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 4: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Microbial, 2021-2034
  • Figure 5: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Plant-based, 2021-2034
  • Figure 6: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Animal-based, 2021-2034
  • Figure 7: Global Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 8: Global Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 9: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Pharmaceuticals, 2021-32
  • Figure 10: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Food and Beverages, 2021-2034
  • Figure 11: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Personal Care & Cosmetics, 2021-32
  • Figure 12: Global Biotech Ingredients Market Revenue (USD Billion) Forecast, By Others, 2021-32
  • Figure 13: Global Biotech Ingredients Market Revenue (USD Billion), by Region, 2025 & 2034
  • Figure 14: Global Biotech Ingredients Market Revenue Share (%), by Region, 2025
  • Figure 15: North America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 16: North America Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 17: North America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 18: North America Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 19: North America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 20: North America Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 21: Europe Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 22: Europe Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 23: Europe Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 24: Europe Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 25: Europe Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 26: Europe Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 27: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 28: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 29: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 30: Asia Pacific Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 31: Asia Pacific Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 32: Asia Pacific Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 33: Latin America Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 34: Latin America Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 35: Latin America Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 36: Latin America Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 37: Latin America Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 38: Latin America Biotech Ingredients Market Revenue Share (%), by Country, 2025
  • Figure 39: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Source, 2025 & 2034
  • Figure 40: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Source, 2025
  • Figure 41: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), By Application, 2025 & 2034
  • Figure 42: Middle East & Africa Biotech Ingredients Market Revenue Share (%), By Application, 2025
  • Figure 43: Middle East & Africa Biotech Ingredients Market Revenue (USD Billion), by Country, 2025 & 2034
  • Figure 44: Middle East & Africa Biotech Ingredients Market Revenue Share (%), by Country, 2025